472 related articles for article (PubMed ID: 31456177)
21. Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management.
Kleibl Z; Kristensen VN
Breast; 2016 Aug; 28():136-44. PubMed ID: 27318168
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of breast cancer.
Marchant DJ
Clin Obstet Gynecol; 1982 Jun; 25(2):387-92. PubMed ID: 7105514
[TBL] [Abstract][Full Text] [Related]
23. BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer.
Wong MW; Nordfors C; Mossman D; Pecenpetelovska G; Avery-Kiejda KA; Talseth-Palmer B; Bowden NA; Scott RJ
Breast Cancer Res Treat; 2011 Jun; 127(3):853-9. PubMed ID: 21409391
[TBL] [Abstract][Full Text] [Related]
24. Low prevalence of germline PALB2 mutations in Australian triple-negative breast cancer.
Wong-Brown MW; Avery-Kiejda KA; Bowden NA; Scott RJ
Int J Cancer; 2014 Jan; 134(2):301-5. PubMed ID: 23824750
[TBL] [Abstract][Full Text] [Related]
25. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Walsh T; Casadei S; Coats KH; Swisher E; Stray SM; Higgins J; Roach KC; Mandell J; Lee MK; Ciernikova S; Foretova L; Soucek P; King MC
JAMA; 2006 Mar; 295(12):1379-88. PubMed ID: 16551709
[TBL] [Abstract][Full Text] [Related]
26. Understanding breast cancer risk -- where do we stand in 2005?
Dumitrescu RG; Cotarla I
J Cell Mol Med; 2005; 9(1):208-21. PubMed ID: 15784178
[TBL] [Abstract][Full Text] [Related]
27. Correlation between selected XRCC2, XRCC3 and RAD51 gene polymorphisms and primary breast cancer in women in Pakistan.
Qureshi Z; Mahjabeen I; Baig R; Kayani M
Asian Pac J Cancer Prev; 2014; 15(23):10225-9. PubMed ID: 25556451
[TBL] [Abstract][Full Text] [Related]
28. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.
Cullinane CA; Lubinski J; Neuhausen SL; Ghadirian P; Lynch HT; Isaacs C; Weber B; Moller P; Offit K; Kim-Sing C; Friedman E; Randall S; Pasini B; Ainsworth P; Gershoni-Baruch R; Foulkes WD; Klijn J; Tung N; Rennert G; Olopade O; Couch F; Wagner T; Olsson H; Sun P; Weitzel JN; Narod SA
Int J Cancer; 2005 Dec; 117(6):988-91. PubMed ID: 15986445
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms and mutations in GSTP1, RAD51, XRCC1 and XRCC3 genes in breast cancer patients.
Al Zoubi MS; Zavaglia K; Mazanti C; Al Hamad M; Al Batayneh K; Aljabali AAA; Bevilacqua G
Int J Biol Markers; 2017 Jul; 32(3):e337-e343. PubMed ID: 28315507
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study.
Han J; Hankinson SE; Ranu H; De Vivo I; Hunter DJ
Carcinogenesis; 2004 Feb; 25(2):189-95. PubMed ID: 14578164
[TBL] [Abstract][Full Text] [Related]
31. Reproductive factors and breast cancer risk among BRCA1 or BRCA2 mutation carriers: results from ten studies.
Pan H; He Z; Ling L; Ding Q; Chen L; Zha X; Zhou W; Liu X; Wang S
Cancer Epidemiol; 2014 Feb; 38(1):1-8. PubMed ID: 24332935
[TBL] [Abstract][Full Text] [Related]
32. Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer.
Rummel SK; Lovejoy L; Shriver CD; Ellsworth RE
Breast Cancer Res Treat; 2017 Aug; 164(3):593-601. PubMed ID: 28503720
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer.
Muendlein A; Rohde BH; Gasser K; Haid A; Rauch S; Kinz E; Drexel H; Hofmann W; Schindler V; Kapoor R; Decker T; Lang AH
J Cancer Res Clin Oncol; 2015 Nov; 141(11):2005-12. PubMed ID: 25971625
[TBL] [Abstract][Full Text] [Related]
34. Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk.
Han J; Hankinson SE; Zhang SM; De Vivo I; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):520-4. PubMed ID: 15066914
[TBL] [Abstract][Full Text] [Related]
35. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.
Moran O; Nikitina D; Royer R; Poll A; Metcalfe K; Narod SA; Akbari MR; Kotsopoulos J
Breast Cancer Res Treat; 2017 Jan; 161(1):135-142. PubMed ID: 27798748
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.
Fu YP; Yu JC; Cheng TC; Lou MA; Hsu GC; Wu CY; Chen ST; Wu HS; Wu PE; Shen CY
Cancer Res; 2003 May; 63(10):2440-6. PubMed ID: 12750264
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the contribution of the three breast cancer susceptibility genes CHEK2, STK11, and PALB2 in non-BRCA1/2 French Canadian families with high risk of breast cancer.
Guénard F; Pedneault CS; Ouellette G; Labrie Y; Simard J; ; Durocher F
Genet Test Mol Biomarkers; 2010 Aug; 14(4):515-26. PubMed ID: 20722467
[TBL] [Abstract][Full Text] [Related]
38. Genetics of triple-negative breast cancer: Implications for patient care.
Afghahi A; Telli ML; Kurian AW
Curr Probl Cancer; 2016; 40(2-4):130-140. PubMed ID: 28340968
[TBL] [Abstract][Full Text] [Related]
39. Functional variant analyses (FVAs) predict pathogenicity in the BRCA1 DNA double-strand break repair pathway.
Loke J; Pearlman A; Upadhyay K; Tesfa L; Shao Y; Ostrer H
Hum Mol Genet; 2015 Jun; 24(11):3030-7. PubMed ID: 25652403
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses.
García-Closas M; Egan KM; Newcomb PA; Brinton LA; Titus-Ernstoff L; Chanock S; Welch R; Lissowska J; Peplonska B; Szeszenia-Dabrowska N; Zatonski W; Bardin-Mikolajczak A; Struewing JP
Hum Genet; 2006 May; 119(4):376-88. PubMed ID: 16485136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
